ConductScience.org, home

Paper36950491

Post-Transplant Immunosuppression in Autoimmune Liver Disease.

Kelly C and 2 others. J Clin Exp Hepatol, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Papers, record 36950491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36950491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Post-Transplant Immunosuppression in Autoimmune Liver Disease.
PubMed
Journal
J Clin Exp Hepatol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.78
iCite
Revised in PubMed
2024-03-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kelly CClaire
2Zen YYoh
3Heneghan MAMichael A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References141

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134605157Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.Am J Transplant2022https://conductscience.org/library/papers/34605157PubMed
232301319Autoimmune Hepatitis: 2019 Update.Gut Liver2020https://conductscience.org/library/papers/32301319PubMed
320347176Primary biliary cirrhosis: a 2010 update.J Hepatol2010https://conductscience.org/library/papers/20347176PubMed
49193175Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.Ann Surg1997https://conductscience.org/library/papers/9193175PubMed
519243003A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.Liver Transpl2009https://conductscience.org/library/papers/19243003PubMed
619790153Risk factors for recurrence of autoimmune hepatitis after liver transplantation.Liver Transpl2009https://conductscience.org/library/papers/19790153PubMed
79482295De-novo autoimmune hepatitis after liver transplantation.Lancet1998https://conductscience.org/library/papers/9482295PubMed
828802875Primary sclerosing cholangitis - a comprehensive review.J Hepatol2017https://conductscience.org/library/papers/28802875PubMed
920590890Liver retransplantation in adults: a single-centre, 25-year experience.HPB (Oxford)2010https://conductscience.org/library/papers/20590890PubMed
1031979326Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease.J Clin Med2020https://conductscience.org/library/papers/31979326PubMed
1110949190Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors.Transplantation2000https://conductscience.org/library/papers/10949190PubMed
1230716203Autoimmune hepatitis: Current and future therapeutic options.Liver Int2019https://conductscience.org/library/papers/30716203PubMed
1327081833Liver transplantation in the United Kingdom.Liver Transpl2016https://conductscience.org/library/papers/27081833PubMed
1431932891An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort.J Gastroenterol2020https://conductscience.org/library/papers/31932891PubMed
1523810223Primary sclerosing cholangitis.Lancet2013https://conductscience.org/library/papers/23810223PubMed
169846512Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?Transplantation1998https://conductscience.org/library/papers/9846512PubMed
1714702528The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.Transplantation2003https://conductscience.org/library/papers/14702528PubMed
1827957759Systematic review: recurrent autoimmune liver diseases after liver transplantation.Aliment Pharmacol Ther2017https://conductscience.org/library/papers/27957759PubMed
199563959Allograft rejection after liver transplantation for autoimmune liver diseases.Liver Transpl Surg1998https://conductscience.org/library/papers/9563959PubMed
2021516069The pattern of late mortality in liver transplant recipients in the United Kingdom.Transplantation2011https://conductscience.org/library/papers/21516069PubMed

See all 141 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42796257Assessment of the Factors That Predict Post-Transplant Mortality in Autoimmune Liver Disease Recipients.Medicina (Kaunas)2026https://conductscience.org/library/papers/42796257PubMed
42544833Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis - To Suppress or Not to Suppress?Aliment Pharmacol Ther2026https://conductscience.org/library/papers/42544833PubMed
42520166Artificial intelligence predicts recurrent autoimmune hepatitis after liver transplantation in a multicenter cohort study.Hepatol Commun2026https://conductscience.org/library/papers/42520166PubMed
39086532Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis.World J Hepatol2024https://conductscience.org/library/papers/39086532PubMed
37945160Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.Clin Liver Dis2024https://conductscience.org/library/papers/37945160PubMed
37693262The Science and Art of Immunosuppression in Liver Transplantation.J Clin Exp Hepatol2023https://conductscience.org/library/papers/37693262PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36950491

GET https://conductscience.org/api/papers/v1/36950491/references?page=2